RNA

Channel:

ThinkMai

Subscribers:

1,480

Published on October 13, 2023 10:00:12 PM ● Video Link: https://www.youtube.com/watch?v=DW38ZJ3Vev8

Duration: 8:18

18 views

0

PNPGE stands for Programmable Nano-Carrier for Precision Gene Editing.
RNA - This video link - https://youtu.be/DW38ZJ3Vev8
📺 New to ThinkMai Start Then? - https//www.youtube.com/channel/UC3P8ggxhxAhwcqydlqFpA8A/
Latest Video
Surf Fishing - https://youtu.be/JamMMqQsH4Y
Chili Field - https://youtu.be/dqjOSMfDR5g
Serenity Inner Relaxation - https://youtu.be/Ok_51e7e2eU
Overview:
The Programmable Nano-Carrier for Precision Gene Editing (PNPGE) is a ground-breaking programmable delivery device developed to meet the demanding conditions mentioned in Target Area 1. PNPGE is a highly efficient, cost-effective, and scalable technology capable of accurately delivering genome editing machinery to an extensive selection of cell types, tissues, and organs.
Key Features:
• Programmability:
PNPGE has a modular design that allows for easy programming of target specificity. A synthetic biology method operates with a library of targeting modules that may prove freely interchanged to adapt to diverse tissue targets.
• Incorporates an innovative control algorithm for contemporaneous modifications in targeting specificity.
• Efficiency:
Delivers and edits at least three distinct cell types, tissue types, or organs with efficiency comparable to or exceeding those known to of current state-of-the-art technology.
• A dual-stage delivery mechanism applies for greater precision and efficacy.
• Biological Mechanism:
Features a well-defined biological mechanism connected to changes in the synthetic biology components, ensuring a clear grasp of how changes relate to the underlying biology.
• With the goal of enhancing programmability, a novel biological signaling system is used.
• Biodistribution and Administration Mode: Comprehensive investigations highlight biodistribution characteristics and appropriate delivery routes.
• Imaging and molecular tracking are applied to confirm precision-guided delivery.
• Independent Review:
• Independent evaluations funded by the NIH show successful delivery and editing performance in large animals that meets the highest scientific requirements.
• Profile of Security:
Extensive safety investigations in experimental animals, in accordance with gene therapy standards, ensure the safety of PNPGE for human usage.
• Preclinical investigations revealed no off-target effects.
• Desired Characteristics:
Objectives many tissue and organ types, providing a broad therapeutic spectrum. Innovative synthetic biology approaches serve to increase efficacy. Shows market potential and fulfills unmet medical requirements.
• Manufacturing processes that are scalable and cost-effective for widespread availability.
Crossing the Blood-Brain Barrier (BBB)
Proposal for a Final Solution Title:
Efficient Non-Viral Blood-Brain Barrier Crossing for Genome Editing using NeuroNanoPulse
Overview:
NeuroNanoPulse, our approach, is a highly efficient non-viral delivery technology developed exclusively for bridging the Blood-Brain Barrier (BBB) and delivering genome editing machinery to clinically relevant brain cell types.
Key Features:
• BBB Traversal:
A unique nanotechnology-based technique is applied for efficient in vivo BBB traversal.
• Integrates pulsatile delivery techniques have been adjusted for BBB penetration without compromising integrity.
• Cell-Type Specificity:
Demonstrates the ability to distribute genome editing machinery to a significant fraction of clinically relevant brain cell types.
• Surface modification with cell-specific ligands allows for precise targeting.
• Non-Viral Delivery: Prevents the constraints associated with viral vectors by using non-viral delivery technology.
• There is no need for recombinant adeno-associated viral vectors.
• Independent Evaluation:
• Independent evaluations backed by the National Institutes of Health confirm successful delivery and editing performance in big animals, ensuring clinical relevance.
• Safety Profile:
NeuroNanoPulse's safety for human use helps to know by rigorous safety studies that adhere to gene therapy guidelines.
• In preclinical studies, no neurotoxicity or adverse effects appeared noted.
• Desired Traits:
Innovatively constructed for efficient BBB traversal while maintaining safety. Synthetic manufacturing processes that are scalable and cost-effective. Deals with significant healthcare demands in neurological illnesses.
• It has the potential for widespread clinical application. PNPGE and NeuroNanoPulse are cutting-edge improvements in programmable gene editing delivery methods that fulfill and surpass the standards established in Target Areas 1 and 2, respectively. Their unique designs, accurate safety profiles, and flexibility position them as strong candidates for consideration in the America COMPETES Act challenge.
#RNA #DNA #PNPGE
RNA